AZA

New York Aquarium Unveils Powerful ‘Washed Ashore’ Experience To Raise Awareness About Ocean Plastic Pollution

Retrieved on: 
Wednesday, May 1, 2024
Tourist Attractions, Arts, Museums, Entertainment, Family, Destinations, Recycling, Events, Concerts, Travel, Consumer, Environmental Issues, Environmental Health, Environment, Parenting, Children, Sea, Central Park Zoo, Zoo, Nature, Prospect Park Zoo, Biodiversity, Animal, Washed Ashore, Partnership, Atlantic Coast, Life, Queens Zoo, Plastic, Adventure, Multimedia, Shark, Bronx Zoo, Private sector, AZA, Magellanic

View the full release here: https://www.businesswire.com/news/home/20240501807460/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240501807460/en/
    The “Washed Ashore: Art to Save the Sea” exhibit is coming to the New York Aquarium (Photo: Business Wire)
    An estimated 9 million tons of plastic enter the ocean annually.
  • Once plastic enters our waterways, it is deadly for many species and negatively impacts animals and people.
  • Admission to the Washed Ashore experience is included with the purchase of a ticket to the New York Aquarium .
  • These sculptures highlight species that are part of the WCS and New York Aquarium local and global ocean conservation efforts.

The Bronx Zoo Hosted the 16th Annual WCS Run for the Wild Today

Retrieved on: 
Saturday, April 27, 2024
Environment, Family, Environmental Issues, Environmental Health, Philanthropy, Consumer, Fund Raising, Foundation, Education, IUCN, Central Park Zoo, Wildlife conservation, Zoo, Prospect Park Zoo, Biodiversity, Male, Partnership, Snow, Bronx Zoo, Female, ZOO, Science, Queens Zoo, Face, Music, Multimedia, Private sector, Wildlife Conservation Society, WCS, Credit, AZA

The WCS Run for the Wild, sponsored by Montefiore Einstein, marking the official start of spring/summer in New York City, returned to the Bronx Zoo today for the 16th year.

Key Points: 
  • The WCS Run for the Wild, sponsored by Montefiore Einstein, marking the official start of spring/summer in New York City, returned to the Bronx Zoo today for the 16th year.
  • View the full release here: https://www.businesswire.com/news/home/20240427289364/en/
    2024 Run for the Wild (Credit: © WCS)
    Five thousand participants ran, jogged, and walked through the Wildlife Conservation Society’s Bronx Zoo in support of wildlife conservation.
  • Each year, the WCS Run for the Wild is dedicated to an animal to raise awareness of the threats they face.
  • WCS and the Bronx Zoo have long been a global leader in snow leopard conservation, thanks in part to funds raised during the annual WCS Run for the Wild.

Critically Endangered Bornean Orangutan Born at Busch Gardens Tampa Bay, Birth Marks Milestone in Orangutan Conservation Efforts

Retrieved on: 
Monday, April 15, 2024
Busch Gardens, IUCN, Bornean orangutan, SSP, AZA, Social media, Busch Gardens Tampa Bay, Female, Amusement park

TAMPA, Fla., April 15, 2024 /PRNewswire/ -- Busch Gardens Tampa Bay today announced the birth of a critically endangered female Bornean Orangutan. The birth signifies a milestone in Orangutan conservation efforts among accredited zoological facilities, like Busch Gardens Tampa Bay, who participate in the Association of Zoos and Aquariums (AZA) Species Survival Plan® (SSP) to ensure the welfare and future prosperity of this newborn and her species.

Key Points: 
  • TAMPA, Fla., April 15, 2024 /PRNewswire/ -- Busch Gardens Tampa Bay today announced the birth of a critically endangered female Bornean Orangutan.
  • Luna remains in recovery as she recuperates from surgery under 24-hour care at Busch Gardens Tampa Bay's state-of-the-art Orangutan house.
  • The Bornean Orangutan is listed as critically endangered status by the International Union for Conservation of Nature (IUCN).
  • Guests interested in following Luna and her newborn's progress are encouraged to follow Busch Gardens Tampa Bay on social media.

Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights

Retrieved on: 
Thursday, February 29, 2024
Research, Autoimmune disease, Anemia, Investment, Lung cancer, Patient, Mirvetuximab soravtansine, PLD, Cancer cell, AZA, Azacitidine, Neoplasm, Clinical trial, TP53, Fusion, Autoimmunity, G&A, Cancer research, NSCLC, AML, ASH, Inflammation, Conference, Safety, Collaboration, Pharmacokinetics, Insurance, Messenger, Research and development, Society, Event, Administration, Citigroup, Publication, Cancer, Pharmaceutical industry

Initial combination data from the Phase 1B clinical trial of SL-172154 in combination with mirvetuximab soravtansine in PROC expected mid-year 2024.

Key Points: 
  • Initial combination data from the Phase 1B clinical trial of SL-172154 in combination with mirvetuximab soravtansine in PROC expected mid-year 2024.
  • Shattuck Closes Financing: On December 21, 2023, Shattuck announced a $50 million public offering of common stock and concurrent private placement of pre-funded warrants.
  • Research and Development (R&D) Expenses: R&D expenses for the quarter ended December 31, 2023, were $15.2 million, as compared to $21.9 million for the quarter ended December 31, 2022.
  • General and Administrative (G&A) Expenses: G&A expenses for the quarter ended December 31, 2023 were $4.4 million, as compared to $4.8 million for the quarter ended December 31, 2022.

16th Annual WCS Run For The Wild to Protect Iconic Snow Leopards & Other Wildlife

Retrieved on: 
Tuesday, March 5, 2024
Men, Tourist Attractions, Arts, Museums, Entertainment, Family, Destinations, Events, Concerts, Travel, Consumer, Philanthropy, Running, Sports, Fund Raising, Women, ZOO, Central Park Zoo, AZA, Multimedia, Education, Wildlife Conservation Society, Queens Zoo, Prospect Park Zoo, WCS, Zoo, Wildlife conservation, Cubs, Cat, Wild, VIP, Snow, Science, IUCN

You probably can’t outrun a snow leopard , but you may be able to help protect them at the 16th annual WCS Run For The Wild 5K run and 3K family fun run/walk on Saturday, April 27, at the Bronx Zoo.

Key Points: 
  • You probably can’t outrun a snow leopard , but you may be able to help protect them at the 16th annual WCS Run For The Wild 5K run and 3K family fun run/walk on Saturday, April 27, at the Bronx Zoo.
  • More than 80 snow leopards have been born at the Bronx Zoo, more than any other zoo in North America.
  • We have long been a global leader in snow leopard conservation, thanks in part to funds raised during the annual WCS Run For The Wild.
  • Register to participate in the 16th annual WCS Run For The Wild and help us make tracks for snow leopards.

Immune-Onc Therapeutics Announces Orphan Drug Designation Granted by US FDA for IO-202 (Anti-LILRB4) for the Treatment of Chronic Myelomonocytic Leukemia (CMML)

Retrieved on: 
Wednesday, February 21, 2024
Oncology, Health, FDA, General Health, Clinical Trials, Pharmaceutical, Biotechnology, AZA, AML, LILRB4, Azacitidine, Marketing, Food, Inflammation, HMA, Therapy, Bone marrow, CMML, Patient, Autoimmunity, Chronic myelomonocytic leukemia, Diagnosis, Acute myeloid leukemia, Pharmaceutical industry

Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a clinical-stage biopharmaceutical company advancing novel therapies in immunology and oncology by targeting myeloid cell inhibitory receptors, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for IO-202 for the treatment of chronic myelomonocytic leukemia (CMML).

Key Points: 
  • Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a clinical-stage biopharmaceutical company advancing novel therapies in immunology and oncology by targeting myeloid cell inhibitory receptors, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for IO-202 for the treatment of chronic myelomonocytic leukemia (CMML).
  • IO-202 received Fast Track Designation for treatment of relapsed or refractory CMML in 2023.
  • In addition, Fast Track and Orphan Drug Designations for IO-202 were granted by the FDA for the treatment of acute myeloid leukemia (AML) in 2022 and 2020, respectively.
  • “We are very proud that the FDA has granted IO-202 Orphan Drug Designation for the treatment of CMML.

Confiscated Tiger Cub Brought to Oakland Zoo for Long-Term Rehabilitation and Care

Retrieved on: 
Friday, February 23, 2024
Zoo, AZA, Big Cat Rescue, Education, Medicine, Pain, Animal, Female, Injury, Surgeon, Calcium, Hope, California Department, Tiger King, Commerce, Safety, History, Nutrient, Cat, Accreditation, Knowledge, Rehabilitation, Legal case, Fracture, Muscle atrophy, Breeding, Running

OAKLAND, Calif., Feb. 23, 2024 /PRNewswire-PRWeb/ -- On Tuesday afternoon, Oakland Zoo, acting as agents for the California Department of Fish and Wildlife, assisted with rescuing an eight-month-old female tiger from a privately owned facility in the western U.S. The female tiger was found to be suffering from numerous improperly healed fractures in her bones. Oakland Zoo's Veterinary Hospital staff performed a thorough physical exam, CT scan, and bloodwork. It was determined that the patient had ten pathological fractures, leading to pain and a lack of mobility. This led to a 50% muscle atrophy in her legs. She was supplemented with nutrients and given the necessary pain medication. "I've treated over 100 cases of rescued big cats, and unfortunately, these injuries can lead to lifelong medical issues," says Dr. Ryan Sadler, Senior Veterinarian at Oakland Zoo.The Zoo's Veterinary Hospital team is working to build her calcium and muscle growth, which can take several weeks to months. Once her bones have built enough calcium, the Zoo's Veterinarians will work with surgeons to determine the next steps in her healing journey. Oakland Zoo veterinarians are cautiously optimistic, though it will take some time, that she will make a full recovery.

Key Points: 
  • Now receiving specialized care at Oakland Zoo's Veterinary Hospital, the eight-month-old tiger has a hopeful future.
  • Oakland Zoo veterinarians are cautiously optimistic, though it will take some time, that she will make a full recovery.
  • We are grateful to serve in a role that gives her hope for brighter days ahead," says Nik Dehejia, CEO of Oakland Zoo.
  • With their expertise, knowledge, and exemplary standards of care, Oakland Zoo is equipped to execute the rehabilitation this rescued female tiger needs to begin her long journey to recovery.

IMMOTION JOINS THE ASSOCIATION OF ZOOS AND AQUARIUMS COMMERCIAL MEMBER ENGAGEMENT COUNCIL

Retrieved on: 
Monday, January 29, 2024
VR, Partnership, AZA, CMEC, Education, Element, Commercial

LOS ANGELES, Jan. 29, 2024 /PRNewswire/ -- Immotion, a global leader in immersive edutainment, is proud to announce its membership in the Association of Zoos and Aquariums (AZA) Commercial Member Engagement Council (CMEC).

Key Points: 
  • LOS ANGELES, Jan. 29, 2024 /PRNewswire/ -- Immotion, a global leader in immersive edutainment, is proud to announce its membership in the Association of Zoos and Aquariums (AZA) Commercial Member Engagement Council (CMEC).
  • This partnership aligns with our commitment to conservation education and our mission to spotlight endangered species.
  • By joining the CMEC, Immotion aims to further its commitment to these elements and contribute to AZA's mission.
  • Rod Findley, President & CEO of Immotion, expressed his enthusiasm about the new partnership: "We are thrilled to join the AZA's Commercial Member Engagement Council.

Denver Zoo Earns American Humane Certification for Animal Welfare

Retrieved on: 
Tuesday, January 23, 2024
Senior, Volunteering, Animal, Ethics, Health, Housing, Happiness, Zoo, Accreditation, Organization, Human, AZA, Elephant, Certification, American Humane

DENVER, Jan. 23, 2024 /PRNewswire-PRWeb/ -- American Humane, the United States' first national humane organization and the world's largest certifier of animal welfare practices, announced that Denver Zoo has again earned the American Humane Certified™ seal and another five-year certification for demonstrating outstanding welfare and treatment of the animals in its care. The Zoo passed a rigorous independent assessment to join a growing number of leading zoological institutions that have earned the American Humane Certified™ designation. This certification closely follows the Zoo's accreditation by the Association of Zoos and Aquariums (AZA) in 2023.

Key Points: 
  • DENVER, Jan. 23, 2024 /PRNewswire-PRWeb/ -- American Humane, the United States' first national humane organization and the world's largest certifier of animal welfare practices, announced that Denver Zoo has again earned the American Humane Certified™ seal and another five-year certification for demonstrating outstanding welfare and treatment of the animals in its care.
  • The Zoo passed a rigorous independent assessment to join a growing number of leading zoological institutions that have earned the American Humane Certified™ designation.
  • The American Humane Certified™ program is the world's first certification program dedicated solely to the welfare of animals in zoological institutions.
  • The program enforces rigorous, science-based and comprehensive criteria for animal welfare, developed by an independent Scientific Advisory Committee comprised of world-renowned leaders in the fields of animal science, animal behavior and animal ethics.

Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024

Retrieved on: 
Monday, January 8, 2024
Autoimmune disease, Completeness, Ovarian cancer, PROC, AZA, TP53, Anemia, Society, Clinical trial, Cancer, Event, Azacitidine, Investment, Webcast, Patient, Safety, PLD, Acceleration, AML, Mirvetuximab soravtansine, Pharmaceutical industry

AUSTIN, TX and DURHAM, NC, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today provided a corporate update and highlighted upcoming key milestones anticipated in 2024.

Key Points: 
  • AUSTIN, TX and DURHAM, NC, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today provided a corporate update and highlighted upcoming key milestones anticipated in 2024.
  • “In 2023, we delivered key safety and efficacy data across our clinical development program for SL-172154 and further strengthened our financial resources, which we believe will carry us beyond upcoming milestones in the year ahead,” said Taylor Schreiber, M.D., Ph.D., Chief Executive Officer of Shattuck Labs.
  • On December 21, 2023, Shattuck announced a $50 million registered offering of common stock and concurrent private placement of pre-funded warrants.
  • Initial combination data from the Phase 1B clinical trial of SL-172154 in combination with mirvetuximab soravtansine in PROC expected mid-year 2024.